Basilea Pharmaceutica Ltd. (0QNA)

Market Open

16 Dec, 09:24

LSE

54. 40

CHF

+1.1

+2.07%

- Market Cap

7.96 P/E Ratio

20% Div Yield

900 Volume

2.9 Eps

53.3 CHF

Previous Close

Day Range

54.35 54.4

Year Range

32.2 54.4

Want to track 0QNA and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 62 days

Overview
Dividends
Earnings

Name	Cons. EPS	Eps
BSLN Basilea Pharmaceutica Ltd. 17 Feb 2026 (In 2 months)	2.6	-
BSLN Basilea Pharmaceutica Ltd. 16 Feb 2026 (In 2 months)	-	-
BSLN Basilea Pharmaceutica Ltd. 3 Dec 2025	-	-
BSLN Basilea Pharmaceutica Ltd. 19 Aug 2025	2.12	1.26
BSLN Basilea Pharmaceutica Ltd. 24 Apr 2025	-	-
BSLN Basilea Pharmaceutica Ltd. 11 Feb 2025	-	-
BSLN Basilea Pharmaceutica Ltd. 13 Aug 2024	-	-
BSLN Basilea Pharmaceutica Ltd. 24 Apr 2024	-	-
BSLN Basilea Pharmaceutica Ltd. 13 Feb 2024	0.93	-
BSLN Basilea Pharmaceutica Ltd. 29 Nov 2023	-	-
BSLN Basilea Pharmaceutica Ltd. 15 Aug 2016	-	-
BSLN Basilea Pharmaceutica Ltd. 29 Feb 2016	-	-
BSLN Basilea Pharmaceutica Ltd. 14 Aug 2015	-	-

0QNA Earnings Reports FAQ

What is the earnings per share (EPS) for 0QNA?

The current EPS is 2.9.

What is the company's earnings growth rate?

Basilea Pharmaceutica Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-16, based on the 0QNA's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Basilea Pharmaceutica Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0QNA at this time, as Basilea Pharmaceutica Ltd has no recent EPS data to calculate it.

Affiliate Program About Terms Privacy Help Contact Us